Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
acetylcysteine + ascorbic acid
- Development stage
- Phase 4
- Lead developer
- Abian Pharmed
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Broncetyl-C is an oral combination of acetylcysteine (600 mg) and ascorbic acid (vitamin C, 75 mg) developed and marketed by Abian Pharmed. Acetylcysteine acts as a mucolytic agent by reducing disulfide bonds in mucoproteins, thereby thinning viscous mucus in the respiratory tract and facilitating its clearance. Ascorbic acid is included to enhance the antioxidant and therapeutic efficacy of acetylcysteine. Broncetyl-C is approved in Iran for the treatment of respiratory diseases characterized by excessive or thick mucus production, such as bronchitis, chronic asthma, pneumonia, and emphysema, and can also serve as an antidote for acetaminophen toxicity.
- Brand names
- Broncetyl-CLumenac-CMuconex-C
- Other names
- acetylcysteine + ascorbic acidacetylcysteine + vitamin C
02
Targets
2-OGDD (Fe(II)/2-oxoglutarate-dependent dioxygenase)SLC7A11 (Cystine-Glutamate Antiporter)TRPA1 (Transient receptor potential cation channel subfamily A member 1)DBH (Dopamine beta-hydroxylase)MUC2 (Mucin-2)P4H (Prolyl 4-hydroxylase subunit alpha-3)
Beyond the preview
Go deeper on acetylcysteine + ascorbic acid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on acetylcysteine + ascorbic acid.